Heterogeneous dysregulation of microRNAs across the autism spectrum
microRNAs (miRNAs) are ~21 nt transcripts capable of regulating the expression of many mRNAs and are abundant in the brain. miRNAs have a role in several complex diseases including cancer as well as some neurological diseases such as Tourette’s syndrome and Fragile x syndrome. As a genetically complex disease, dysregulation of miRNA expression might be a feature of autism spectrum disorders (ASDs). Using multiplex quantitative polymerase chain reaction (PCR), we compared the expression of 466 human miRNAs from postmortem cerebellar cortex tissue of individuals with ASD (n = 13) and a control set of non-autistic cerebellar samples (n = 13). While most miRNAs levels showed little variation across all samples suggesting that autism does not induce global dysfunction of miRNA expression, some miRNAs among the autistic samples were expressed at significantly different levels compared to the mean control value. Twenty-eight miRNAs were expressed at significantly different levels compared to the non-autism control set in at least one of the autism samples. To validate the finding, we reversed the analysis and compared each non-autism control to a single mean value for each miRNA across all autism cases. In this analysis, the number of dysregulated miRNAs fell from 28 to 9 miRNAs. Among the predicted targets of dysregulated miRNAs are genes that are known genetic causes of autism such Neurexin and SHANK3. This study finds that altered miRNA expression levels are observed in postmortem cerebellar cortex from autism patients, a finding which suggests that dysregulation of miRNAs may contribute to autism spectrum phenotype.
KeywordsAutism spectrum disorder miRNA Postmortem tissue Cerebellum
We thank the Autism Tissue Program, Harvard Brain Bank and The Maryland Tissue Bank for the tissue samples. We thank Dr. Margaret Bauman for tissue specimens. The National Alliance for Autism Research (NAAR-Autism Speaks) and the W.M. Keck Foundation supported this research. A Young Investigator grant from the Cure Autism Now Foundation supported Yuhei Nishimura.
- 1.Centers for disease control (2007) Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56(1):12–28Google Scholar
- 5.Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, Raynaud M, Ronce N, Lemonnier E, Calvas P et al (2004) X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74(3):552–557CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L (2006) Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11(1):1, 18–28Google Scholar
- 41.Wellcome Trust Sanger Institute [http://microrna.sanger.ac.uk/sequences/]
- 45.TargetScan Prediction of microRNA Targets [http://www.targetscan.org/]
- 47.Locke DP, Sharp AJ, McCarroll SA, McGrath SD, Newman TL, Cheng Z, Schwartz S, Albertson DG, Pinkel D, Altshuler DM et al (2006) Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 79(2):275–290CrossRefPubMedPubMedCentralGoogle Scholar
- 49.Autism Tissue Program [http://www.brainbank.org/]
- 50.Harvard Brain Tissue Resource Center [http://www.brainbank.mclean.org/]
- 51.Brain and Tissue Bank for Developmental Disorder University of Maryland [http://medschool.umaryland.edu/BTBank/]
- 57.Ensembl [http://www.ensembl.org/Homo_sapiens/]
- 58.The Gene Ontology [http://www.geneontology.org/]